Tags: Drug.

Emtricitabine/tenofovir/efavirenz (INNs trade names Atripla ® Viraday ®) is a fixed-dose combination drug for the treatment of HIV infection. It combines Gilead Sciences’s tenofovir and emtricitabine (already available in the anti-HIV combination Truvada ®) with Merck & Co’s efavirenz into a fixed-dose pill.

Loading...

This page contains content from the copyrighted Wikipedia article "Emtricitabine/tenofovir/efavirenz"; that content is used under the GNU Free Documentation License (GFDL). You may redistribute it, verbatim or modified, providing that you comply with the terms of the GFDL.